RaymondDennisPrattMDFACP

PubMed

• 1 citations
  Letter regarding 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'.
  Michael Smyth, Raymond D. Pratt> ;Kidney International. 2008 Aug 2
• 87 citations
  A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Methylphenidate Transdermal System in Pediatric Patients With Attention-Deficit/Hyperactivity D...
  Robert L. Findling, Oscar G. Bukstein, Raun D. Melmed, Frank A. Lopez, Floyd R. Sallee, L. Eugene Arnold, Raymond D. Pratt> ;The Journal of Clinical Psychiatry. 2008 Jan 15
• 22 citations
  Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
  William B. Smith, James A. Dowell, Raymond D. Pratt> ;Clinical Therapeutics. 2007 Jul 1
• 102 citations
  Donepezil HCl (E2020) Maintains Functional Brain Activity in Patients With Alzheimer Disease: Results of a 24-Week, Double-Blind, Placebo-Controlled Study
  Larry E. Tune, Paul J. Tiseo, John Ieni, Carlos Perdomo, Raymond D. Pratt, John R. Votaw, R.D. Jewart, John M. Hoffman> ;The American Journal of Geriatric Psychiatry. 2003 Mar 1
• 48 citations
  Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits.
  Raymond D. Pratt, Carlos Perdomo> ;Annals of the New York Academy of Sciences. 2002 Nov 1
• 25 citations
  The induction of ATP energized mitochondrial volume changes by carcinogenic N-hydroxy-N-acetyl-aminofluorenes when combined with showdomycin. A unitary hypothesis for ...
  Herbert I. Hadler, Barbra G. Daniel, Raymond D. Pratt> ;The Journal of Antibiotics. 1971 Jul 25
• Join now to see all

Journal Articles

• A balance study comparing dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers.  
  Martin P, Wang P, Robinson A, Poole L, Dragone J, Smyth M, Pratt R, AJKD
• Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy.  
  Wilson,R., Zhang,P., Smyth,M., and Pratt,R, Curr. Med. Res. Opin
• Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study.  
  Sprague,S.M., Ross,E.A., Nath,S.D., Zhang,P., Pratt,R.D., and Krause,R, Clin. Nephrol
• Reply: A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report.  
  Smyth,M.D. and Pratt,R.D, Nephrol. Dial. Transplant
• Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years.  
  Malluche, HH, Pratt, R, Clin. Nephrol
• Hyperphosphatemia of chronic kidney disease.  
  Hruska, KA, Matthew S, Lund R, Qiu P, and Pratt R, Kidney Int
• Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients.  
  Kwan JT, Pratt RD, Curr Med Res Opin
• Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.  
  Spinowitz BS, Pratt RD, Curr Med Res Opin
• Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following mult...  
  Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA, Br.J.Clin.Pharmacol
• Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple ora...  
  Nagy CF, Kumar D, Perdomo CA, Wason S, Cullen EI, Pratt RD, Br.J.Clin.Pharmacol
• Steady-state pharmacokinetics and safety of donepezil HCl in subjects with moderately impaired renal function.  
  Nagy CF, Kumar D, Cullen EI, Bolton WK, Marbury TC, Gutierrez MJ, Hutman HW, Pratt RD, Br.J.Clin.Pharmacol
• Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients.  
  Reyes JF, Vargas R, Kumar D, Cullen EI, Perdomo CA, Pratt RD, Br.J.Clin.Pharmacol
• Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled tr...  
  Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG, Int.J.Geriatr.Psychiatry
• Donepezil in vascular dementia: a randomized, placebo-controlled study.  
  Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD, Neurology
• Donepezil: tolerability and safety in Alzheimer's disease.  
  Pratt RD, Perdomo CA, Surick IW, Ieni JR, Int.J.Clin.Pract
• Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia.  
  Pratt RD, J.Neurol.Sci
• A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients.  
  Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD, Neurology
• Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study. Eur.  
  Rogers SL, Doody RS, Pratt RD, Ieni JR, Neuropsychopharmacol
• Mitochondrial phosphate transport. Import of the H+/Pi symporter and role of the presequence.  
  Pratt RD, Ferreira GC, Pedersen PL, J.Biol.Chem
• Mitochondrial proton/phosphate transporter. An antibody directed against the COOH terminus and proteolytic cleavage experiments provides new insights about its membran...  
  Ferreira GC, Pratt RD, Pedersen PL, J.Biol.Chem
• Energy-linked anion transport. Cloning, sequencing, and characterization of a full length cDNA encoding the rat liver mitochondrial proton/phosphate symporter.  
  Ferreira GC, Pratt RD, Pedersen PL, J.Biol.Chem
• Inhibition of Na+-dependent phosphate transport by group-specific covalent reagents in rat kidney brush border membrane vesicles. Evidence for the involvement of tyros...  
  Pratt RD, Pedersen PL, Arch.Biochem.Biophys
• Purification and reconstitution of the phosphate transporter from rat liver mitochondria.  
  Kaplan RS, Pratt RD, Pedersen PL, Methods Enzymol
• Purification and characterization of the reconstitutively active phosphate transporter from rat liver mitochondria.  
  Kaplan RS, Pratt RD, Pedersen PL, J.Biol.Chem
• Thyroid hormone. Aldosterone antagonism in cultured epithelial cells. Biochim.  
  Pratt RD, Johnson JP, Biophys.Acta
• Join now to see all

Abstracts/Posters

• Purification and Characterization of the Reconstitutively Active Pi/H+ Symporter from Rat Liver Mitochondria.
  Kaplan, R.S., Pratt, R.D. and Pedersen, P.L, ASBC Meeting, Washington, D.C
• Inactivation of the rat kidney brush border Na+-phosphate co-transporter by 7-Chloro-4-Nitrobenzo-2-Oxa-1,3-Diazole (NBD-Cl).
  Pratt, R.D. and Pedersen, P.L, Xth International Society of Nephrology, London England
• Rat liver mitochondrial phosphate transporter: cloning, sequencing and characterization of a full-length cDNA.
  Ferreria, G.F., Pratt, R.D. and Pedersen, P.L, FASEB-ASCB meeting. San Francisco, CA
• Methylamine transport in S. cerevisiae.. A model for ammonium transport across cell membranes.
  Pratt, R.D, ASN 24th Annual Meeting, Baltimore
• Tolerability and safety of donepezil in Alzheimer’s disease patients: integrated results from the clinical trials program.
  Ieni, John, Pratt, Raymond D. and Perdomo, C.A, ECNP Paris France
• Donepezil improves cognition and global function in Alzheimer’s disease: Results from US and multinational Phase III clinical trials.
  Petit, H., Doody, R.S., and Pratt, R.D, ECNP Paris France
• Pharmacokinetics and safety of concurrent donepezil HCI andlevodopa/carbidopa administration in subjects with Parkinson's disease.
  Okereke C, Kumar D, Cullen E, Pratt RD, Hahne W, Neurology
• Estimating the binding capacity of available phosphate binders: a rational basis for prescribing.
  Copley JB, Pratt R, and Smyth, M, Oral Presentation Annual Dialysis Conference
• Toward A Rational Basis For Phosphate Binder Prescribing: Estimating The Binding Capacity Of Available Binders.
  Pratt, R and Smyth, M, ASN Scientific Sessions
• Reduction of dietary phosphorus absorption with lanthanum carbonate and sevelamer carbonate: a balance study.
  Pratt R, Martin P, Poole L and Dragone J, NKF Clinical Meetings
• The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.
  Pierce D, Pratt R, Martin P and Poole L, NKF Clinical Meetings
• Effective Reduction of Serum Phosphorus using Lanthanum Carbonate, with fewer tablets than Sevelamer Hydrochloride.
  Raymond Pratt and Michael Smyth, XLIV ERA-EDTA Congress, Barcelona, Spain
• Is One Year sufficient to observe Changes in Renal Osteodystrophy? Evaluation of Serial Bone Biopsies.
  Raymond Pratt and Michael Smyth, XLIV ERA-EDTA Congress, Barcelona, Spain
• Lanthanum Carbonate versus Standard Therapy: No Difference in the Evolution of Renal Osteodystrophy in a Large Patient Population.
  Raymond Pratt and Michael Smyth, XLIV ERA-EDTA Congress, Barcelona, Spain
• Donepezil-treated patients with vascular dementia demonstrate cognitive and global benefits: results from Study 308, a 24-week, randomized, double-blind, placebo-contr...
  S Salloway, R Pratt, C Perdomo, and The Donepezil 308 Study Group, Neurobiol Aging
• Donepezil improves cognition in patients with vascular dementia: results from Study 307, a 24-week, randomized, double-blind, placebo-controlled trial.
  G Roman, R Pratt, C Perdomo, and The Donepezil 307 Study Group, Neurobiol Aging
• Patients with vascular dementia differ from patients with Alzheimer's disease with respect to population characteristics and pattern of cognitive decline.
  C Perdomo, R Pratt, and the Donepezil 307 and 308 Study Groups, Neurobiol Aging
• Donepezil is well tolerated in patients with vascular dementia: a comparison of safety and tolerability results from randomized, placebo-controlled trials in vascular ...
  R Pratt, C Perdomo, and The Donepezil 307 and 308 Study Groups, Neurobiol Aging
• Effficacy of Lanthanum Carbonate monotherapy in CKD stage 5 patients previously receiving alternative phosphate binder therapy.
  Hutchison, A and Pratt, RD, ISN Nexus Symposium
• Lanthanum Carbonate: No evidence of adverse effects on liver after 6 years of treatment in patients with CKD Stage 5.
  Hutchison, A and Pratt, RD, ISN Nexus Symposium, ISN Nexus Symposium
• Evolution of Renal Osteodystrophy over 1 and 2 years during treatment with Lanthanum Carbonate or standard phosphate binders.
  Malluche, HH and Pratt, RD, ISN Nexus Symposium, ASN Annual Meeting
• Serum Phosphorus levels are maintained and tablet burden is reduced by converting to lanthanum carbonate.
  Pratt, RD, ISN Nexus Symposium, ASN Annual Meeting
• Epoetin Delta for the Treatment of Anemia in Patients with CKD Not Requiring Hemodialysis,
  Pratt, RD, ASN Annual Meeting
• Pharmacokinetics of Epoetin Delta: A New Erythropoietin Produced by Gene-Activation in a Human Cell Line.
  Dowell, JA and Pratt, RD, ASN Annual Meeting
• Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
  R Pratt, G Wilcock, A Whitehead, J Grimley Evans, J Birks, C Perdomo, J Am Geriatr Soc
• Join now to see all